Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.

Zhang JY, Li YN, Mu X, Pan ZL, Liu WB

Open source

DOI
10.26355/eurrev_201812_16623
Published
2018 Dec
Container
European review for medical and pharmacological sciences
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.26355/eurrev_201812_16623,
  title = {Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.},
  author = {Zhang JY and Li YN and Mu X and Pan ZL and Liu WB},
  year = {2018},
  journal = {European review for medical and pharmacological sciences},
  doi = {10.26355/eurrev_201812_16623},
  url = {https://doi.org/10.26355/eurrev_201812_16623}
}

RIS

TY  - JOUR
TI  - Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.
AU  - Zhang JY
AU  - Li YN
AU  - Mu X
AU  - Pan ZL
AU  - Liu WB
PY  - 2018
JO  - European review for medical and pharmacological sciences
DO  - 10.26355/eurrev_201812_16623
UR  - https://doi.org/10.26355/eurrev_201812_16623
ER  - 

APA

JY, Z., YN, L., X, M., ZL, P., & WB, L. (2018). Targeted regulation of miR-195 on MAP2K1 for suppressing ADM drug resistance in prostate cancer cells.. European review for medical and pharmacological sciences. https://doi.org/10.26355/eurrev_201812_16623

Source records